Outlook Therapeutics, Inc. Skyrocketed

Fri, Mar 15, 2024 at 07:15 PM
Outlook Therapeutics, Inc. Skyrocketed

Outlook Therapeutics, Inc. (OTLK:NASDAQ) shot up at $8.24, a gain of 43.8%. On Fri, Mar 15, 2024, OTLK:NASDAQ hit a New 2-Week High of $8.24. The stock got featured on our News Catalysts scanner on Tue, Mar 12, 2024 at 11:28 AM in the 'SPLIT' category. From Fri, Mar 01, 2024, the stock recorded 50.00% Up Days and 9.09% Green Days

The stock spiked on Fri, Mar 15, 2024 at $10.72 with a volume of 2M+.

About Outlook Therapeutics, Inc. (OTLK:NASDAQ)

Oncobiologics Inc is a clinical stage biopharmaceutical company. It is focused on identifying, developing, manufacturing and commercializing complex mAb therapeutics. The company has introduced BioSymphony Platform to produce high-quality innovative and biosimilar mAb candidates in an efficient and cost-effective manner.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.